Immunopathologia Persa

Scope & Guideline

Exploring Innovative Insights in Immunopathology

Introduction

Delve into the academic richness of Immunopathologia Persa with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN2423-8015
PublisherNIKAN RESEARCH INST
Support Open AccessNo
CountryIran
TypeJournal
Convergefrom 2019 to 2024
AbbreviationIMMUNOPATHOL PERSA / Immiunopathol. Persa
Frequency2 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressNO 8, 23 LN, FARABI NORTH ST, FREIBURG AVE, PO BOX 81655-963, ISFAHAN 81687-95341, IRAN

Aims and Scopes

Immunopathologia Persa focuses on the intersection of immunology and pathology, addressing various aspects of disease mechanisms, diagnostic strategies, and therapeutic interventions. The journal publishes original research, systematic reviews, and clinical studies that contribute to understanding immunological responses in various diseases.
  1. Immunological Responses in Disease:
    Research investigating how the immune system responds to various diseases, including cancer, infectious diseases, and autoimmune disorders. This includes studies on biomarkers, immune profiling, and the role of different immune cells.
  2. Clinical Pathology and Diagnostics:
    Studies that enhance diagnostic approaches in pathology, such as the evaluation of histopathological findings, imaging techniques, and laboratory tests to improve disease detection and management.
  3. Therapeutic Interventions and Clinical Trials:
    Clinical studies evaluating the efficacy and safety of therapeutic interventions, including pharmacological treatments, surgical approaches, and novel therapies in various patient populations.
  4. Cancer Research and Biomarkers:
    Exploration of cancer-related biomarkers, mechanisms of tumorigenesis, and the impact of immunotherapy and other treatment modalities on cancer progression and patient outcomes.
  5. Public Health and Epidemiology:
    Investigation into the epidemiological aspects of diseases, particularly infectious diseases like COVID-19, and their implications for public health policy and practice.
Recent publications in Immunopathologia Persa reveal several trending and emerging themes that highlight the journal's responsiveness to current health challenges and advancements in medical science.
  1. COVID-19 Research:
    A significant increase in studies related to COVID-19, including clinical outcomes, treatment efficacy, and the impact of the virus on various patient populations. This trend is reflective of the global health crisis and the need for ongoing research in infectious diseases.
  2. Immunotherapy and Cancer Treatment:
    Growing interest in immunotherapy approaches for cancer treatment, including studies on biomarkers for therapy response and the mechanisms of immune evasion by tumors, indicating a shift towards personalized medicine.
  3. Microbiome and Disease Interactions:
    Emerging research on the role of the microbiome in disease pathogenesis and treatment responses, highlighting the complex interactions between microbiota and the immune system.
  4. Systematic Reviews and Meta-Analyses:
    An increase in the publication of systematic reviews and meta-analyses that synthesize evidence from multiple studies, which aids in establishing comprehensive guidelines and recommendations for clinical practice.
  5. Telemedicine and Remote Patient Monitoring:
    Research exploring the impact of telemedicine and digital health technologies on patient management, especially during and after the COVID-19 pandemic, reflecting a shift towards innovative healthcare delivery models.

Declining or Waning

As the journal evolves, certain themes appear to be declining in prominence, indicating a shift in focus towards more contemporary issues in immunopathology and clinical research.
  1. Traditional Pathology Techniques:
    There seems to be a reduction in studies focused solely on classical pathology techniques without integration of modern immunological approaches, suggesting a move towards more holistic and interdisciplinary research.
  2. Viral Infections without Immunological Context:
    Research on viral infections that do not incorporate an immunological perspective is becoming less frequent, possibly due to the increasing emphasis on understanding immune responses in the context of infectious diseases.
  3. General Reviews without Novel Insights:
    The frequency of general reviews that do not provide novel insights or advancements in the field is declining, indicating a preference for original research and systematic reviews that contribute significantly to the existing body of knowledge.
  4. Non-clinical Laboratory Studies:
    There appears to be a waning interest in non-clinical laboratory studies that do not translate into clinical applications, reflecting a trend towards practical, patient-oriented research.

Similar Journals

VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY

Advancing veterinary science through immunological insights.
Publisher: ELSEVIERISSN: 0165-2427Frequency: 14 issues/year

Veterinary Immunology and Immunopathology is a premier journal published by Elsevier, dedicated to advancing the field of veterinary science through rigorous investigations into the immunological mechanisms that underpin disease resistance, pathogenesis, and therapeutic interventions in animals. With an established history since 1979, this journal has consistently provided a platform for high-quality research, bridging the gap between immunology and veterinary medicine. The current impact factor reflects its significance within the field, particularly noted for its Q3 ranking in Immunology and Q2 in miscellaneous Veterinary categories as of 2023. The journal caters to a diverse audience, from seasoned researchers to students, by publishing original research, reviews, and case studies that explore pivotal topics such as vaccine development, immune response in various species, and the role of genetics in immunological disorders. Notably, it is indexed in Scopus, where it ranks in the top percentile of veterinary science disciplines, enhancing its visibility and impact within the scientific community. For those seeking to stay at the forefront of veterinary immunology, this journal is an invaluable resource.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Pioneering Discoveries in Immunology and Allergy
Publisher: OXFORD UNIV PRESSISSN: 0009-9104Frequency: 12 issues/year

Clinical and Experimental Immunology, published by Oxford University Press, is a premier journal that has been a cornerstone in the field of immunology since its inception in 1966. With an ISSN of 0009-9104 and an E-ISSN of 1365-2249, this journal holds a significant position in academic research, currently ranking in the Q2 category for both Immunology and Allergy (2023). Its impactful contributions are reflected in its Scopus rankings, where it stands at Rank #63 out of 233 in Immunology and Allergy, placing it in the 73rd percentile, and Rank #73 out of 236 in Immunology and Microbiology. Researchers, healthcare professionals, and students will find this journal an invaluable resource for cutting-edge studies, reviews, and clinical advancements in the ever-evolving domain of immunology. While the publication does not offer open-access options, it remains a pivotal platform for disseminating knowledge that impacts both clinical practice and experimental research.

Journal of Translational Medicine

Advancing Healthcare through Translational Insights.
Publisher: BMCISSN: Frequency: 1 issue/year

Journal of Translational Medicine, published by BMC in the United Kingdom, stands at the forefront of biomedical research, bridging the gap between laboratory discoveries and clinical applications. Established in 2003 as an Open Access journal, it has garnered significant recognition, achieving a Q1 quartile ranking in both Biochemistry, Genetics and Molecular Biology and Medicine categories as of 2023. With an impressive Scopus rank of 38 out of 636 in General Medicine and 33 out of 221 in General Biochemistry, Genetics and Molecular Biology, the journal is committed to disseminating high-quality, peer-reviewed research that impacts healthcare and informs clinical practices. By facilitating free access to groundbreaking studies, the Journal of Translational Medicine aims to enhance collaboration among researchers, professionals, and students in the scientific community, fostering advancements in translational research well into the future.

INFLAMMATION RESEARCH

Charting new territories in inflammation and immunity.
Publisher: SPRINGER BASEL AGISSN: 1023-3830Frequency: 12 issues/year

INFLAMMATION RESEARCH, published by SPRINGER BASEL AG, serves as a pivotal journal in the fields of Immunology and Pharmacology, with notable rankings of Q2 in Immunology and Q1 in Pharmacology as of 2023. With an ISSN of 1023-3830 and an E-ISSN of 1420-908X, this esteemed journal, located in Basel, Switzerland, has been at the forefront of advancing our understanding of inflammatory processes since its inception in 1995. Covering research trends and breakthroughs until 2024, it significantly contributes to both the theoretical frameworks and practical applications within its discipline, boasting a strong Scopus ranking of #40/313 in Pharmacology and #56/236 in Immunology, placing it in the top percentiles for its field. Although it does not offer Open Access options, the journal remains an invaluable resource for researchers, professionals, and students committed to unraveling the complexities of inflammation and its implications in health and disease.

JOURNAL OF IMMUNOLOGY

Empowering the Future of Immune Research
Publisher: AMER ASSOC IMMUNOLOGISTSISSN: 0022-1767Frequency: 24 issues/year

Welcome to the JOURNAL OF IMMUNOLOGY, a prestigious publication associated with the American Association of Immunologists and dedicated to advancing the field of immunology. With a rich history dating back to 1945, this journal is renowned for its high-impact research, evident in its notable 2023 Q1 rankings in both Immunology and Allergy, as well as its strong positions in Scopus rankings—Rank #68 in Immunology and Allergy and Rank #79 in Immunology and Microbiology. Although it operates on a subscription basis, its commitment to publishing cutting-edge studies ensures that it remains a vital resource for scientists, healthcare professionals, and students alike. As the journal continues to pave the way for innovative research and breakthroughs in immunological science, it facilitates a platform for dialogue and discovery among researchers and practitioners across the globe.

International Immunopharmacology

Fostering Knowledge in the Dynamic Field of Immunopharmacology
Publisher: ELSEVIERISSN: 1567-5769Frequency: 12 issues/year

International Immunopharmacology, published by Elsevier, stands as a prominent journal within the disciplines of immunology and pharmacology. With an ISSN of 1567-5769 and an E-ISSN of 1878-1705, this esteemed journal is based in the Netherlands and features a robust commitment to disseminating high-quality research from its inception in 2001 through 2024. The journal has achieved impressive rankings, securing a Q1 category in Pharmacology and Q2 in both Immunology and Immunology and Allergy as of 2023. With its strategic focus on bridging the gap between immunology and pharmacological applications, International Immunopharmacology attracts a diverse readership, including researchers, healthcare professionals, and students interested in the latest advancements in therapeutic agents and immune system modulation. Furthermore, it offers an open access option, enhancing the accessibility and reach of its invaluable content. As a pivotal resource in the field, this journal not only facilitates the exchange of innovative ideas but also fosters a deeper understanding of the complexities of immunopharmacology in today’s research landscape.

CYTOKINE

Transforming insights into the mechanisms of health and disease.
Publisher: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTDISSN: 1043-4666Frequency: 12 issues/year

CYTOKINE is a prestigious peer-reviewed journal published by Academic Press Ltd - Elsevier Science Ltd, dedicated to advancing the field of immunology, biochemistry, and related biomedical sciences since its inception in 1989. With an ISSN of 1043-4666 and an E-ISSN of 1096-0023, this journal serves as a vital resource for researchers and professionals alike, offering cutting-edge research findings that delve into the roles and mechanisms of cytokines in health and disease. Recognized for its impactful contributions, CYTOKINE currently ranks in the Q2 quartile across several categories, including Biochemistry, Hematology, and Immunology, indicating its significant influence in these fields. Despite not offering open access, the journal maintains a high-quality standard, as evidenced by its robust Scopus rankings, including a notable 80th percentile in Medicine and Hematology. Researchers and students are encouraged to explore the latest findings and methodologies via CYTOKINE, as it continues to shape the future landscape of cytokine research and application.

American Journal of Clinical and Experimental Immunology

Exploring the Frontiers of Clinical and Experimental Immunology
Publisher: E-CENTURY PUBLISHING CORPISSN: Frequency: 6 issues/year

Welcome to the American Journal of Clinical and Experimental Immunology, a premier publication dedicated to advancing the fields of clinical and experimental immunology. Published by E-CENTURY PUBLISHING CORP, this journal provides a platform for groundbreaking research, case studies, and comprehensive reviews that contribute to our understanding of the immune system and its implications for health and disease. With a focus on disseminating innovative findings and enhancing the dialogue among researchers, practitioners, and students, the journal aims to bridge the gap between laboratory discoveries and clinical applications. Although specific metrics such as the impact factor and Scopus ranks are currently not provided, the journal is committed to maintaining high standards of scholarly publishing and fostering open access to vital research. Located in Madison, WI, and available online via its E-ISSN 2164-7712, this journal is a valuable resource for those wishing to explore the intricacies of immunological research and its applications in clinical practice.

JOURNAL OF CLINICAL IMMUNOLOGY

Shaping the Future of Immune Disease Management
Publisher: SPRINGER/PLENUM PUBLISHERSISSN: 0271-9142Frequency: 8 issues/year

JOURNAL OF CLINICAL IMMUNOLOGY, published by SPRINGER/PLENUM PUBLISHERS, is a leading journal in the field of immunology, with an impressive standing as reflected in its Q1 ranking in both Immunology and Immunology and Allergy for 2023. With a history of publication dating back to 1981 and an E-ISSN of 1573-2592, this journal aims to disseminate cutting-edge research on diagnostic methods, therapeutic strategies, and understanding the mechanisms underlying immune responses. Its significant impact is underscored by its Scopus rankings, where it is placed in the top 15% of journals covering immunology and microbiology. The journal does not currently operate under an Open Access model, yet offers a robust platform for sharing essential findings that contribute to advancements in clinical immunology. As a resource for researchers, professionals, and students, the JOURNAL OF CLINICAL IMMUNOLOGY is pivotal in fostering dialogue and disseminating knowledge that enhances our understanding of immune-related diseases.

BMC IMMUNOLOGY

Bridging Gaps in Immune System Understanding
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Immunology is a prominent open-access journal published by BMC that has been at the forefront of immunological research since its inception in 2000. Based in the United Kingdom, this journal aims to advance the understanding of immune system functions and disorders through high-quality, peer-reviewed articles. With an impressive scope encompassing various facets of immunology, BMC Immunology has earned a Q3 ranking in the Immunology category according to the 2023 category quartiles, demonstrating its growing impact and relevance in the scientific community. Researchers and professionals will find valuable insights in its array of published works, spanning both foundational studies and innovative applications. The journal's commitment to open access ensures that cutting-edge research is freely available, fostering collaboration and advancement in the field. For those looking to stay updated on the latest developments in immunology, BMC Immunology stands as an essential resource for researchers, professionals, and students alike.